Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners
Versandkostenfreie Lieferung!
Lieferzeit: 7-14 Werktage
- Artikel-Nr.: 10388945
Beschreibung
Marianne Davies & Beth Eaby-Sandy
Chapter 2. Introduction to Mutation Testing
Vanna Dest, Kathryn Medow
Chapter 3. Nursing Considerations with EGFR inhibitors in NSCLC
Michelle Turner
Chapter 4. Nursing Considerations with ALK and ROS1 inhibitors in NSCLC
Beth Eaby-Sandy
Chapter 5. BRAF in Non-Small Cell Lung Cancer
Helen Shih
Chapter 6. Mechanisms of acquired resistance to targeted therapy in NSCLC: Role of Repeat Biopsy and Nursing Considerations
Emily Duffield
Chapter 7. The Impact and Toxicity of Checkpoint Inhibitors in Management of Lung Cancer.
Stephanie Crawford Andrews, Marianne Davies
Chapter 8. The Role of Anti-Angiogenic Agents (VEGF)
Melinda Oliver and Elizabeth S. Waxman
Chapter 9. Nursing Considerations for Patients Treated with Targeted Therapies
Kelly E. Goodwin, Marianne Davies
Eigenschaften
Breite: | 156 |
Gewicht: | 253 g |
Höhe: | 8 |
Länge: | 233 |
Seiten: | 120 |
Sprachen: | Englisch |
Autor: | Beth Eaby-Sandy, Marianne Davies |